This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Freelance translator and/or interpreter, Verified site user
Data security
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Translation - English Herpesviruses are large animal viruses consisting of double-stranded DNA genomes. Over 150 strains of the virus have been isolated from a range of animals. In addition to mammals, they have been identified in birds, amphibians, reptiles and fish and it is reasonable to assume that further research will demonstrate that species-specific herpesviruses exist in all vertebrates. A total of 8 varieties of human-specific herpesviruses have been identified: Herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-2), Varicella-zoster virus (VZV), human cytomegalovirus (HCMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV8). The latter 3 were isolated soon after the emergence of AIDS.............
The concept of using viruses in the treatment of cancer has been around for some time. During the 1950s the National Institutes of Health (NIH) in the United States used the recently isolated wild-type human adenovirus in cervical cancer clinical trials. Several similar attempts using different viruses were made sporadically over the following decades but it was not until the 1990s when research began in earnest. This was due, in part, to a greater understanding of viruses themselves but also to progress in the field of genetic engineering. The application of herpes simplex viruses in human studies and clinical trials was promoted by the development of mutants such as HSV-1716 and G207 in the UK and the USA.
More
Less
Experience
Years of experience: 16. Registered at ProZ.com: Jun 2011.
Experience in the scientific fields with a B.Sc. in Molecular Biology and several years experience of working in the pharmaceutical industry in Japan. I have level 1 of the Japanese Language proficiency exam and a Ph.D. in Japanese studies. Translation projects undertaken in the last couple of years include a series of articles on the treatment of pharmaceutical drug poisonings, articles on cardiac rehabilitation, prevention of renal disease and treatment of esophageal-gastric varices. Pharmaceutical marketing surveys, hospital discharge summaries, adverse reaction reports, medical device instruction leaflets, pharmaceutical guidelines, clinical trial protocols, clinical trial agreements, and approval applications for medical devices.Volunteer translator to a small volunteer group which provides financial aid to local charities.
Keywords: Japanese-English translator, pharmaceuticals, genetics, biology, Meiji history
Portfolio